Email Article To A Friend

Valeant to buy Bausch & Lomb in $8.7B deal

*Your name:

*Your e-mail address:

*Your friend's name:

*Your friend's e-mail address:

Your message:
Bausch & Lomb Holdings Inc. has agreed to be acquired by Valeant Pharmaceuticals International Inc. for $8.7 billion in cash. An investor group led by private-equity firm Warburg Pincus LLC will receive roughly $4.5 billion and some $4.2 billion will be used to repay Bausch & Lomb's outstanding debt.">
REGISTER      |      HOME